Kevin Pruitt received a B.S. in Chemical Engineering from UT-Austin and completed his Ph.D. training in Pharmacology as an N.S.F. Predoctoral Fellow under the direction of Channing Der, Ph.D., at UNC-Chapel Hill. He then continued postdoctoral studies as an American Cancer Society Postdoctoral Fellow at the Johns Hopkins School of Medicine under Stephen Baylin, M.D. Dr. Pruitt became an assistant professor at the LSU Health Sciences Center – Shreveport in 2006 and currently directs a very successful research program for which he has secured NIH/NCI funding (R01). The Pruitt laboratory has made major contributions in the study of sirtuin proteins and cancer epigenetics and has published papers in high impact science journals. Dr. Pruitt serves as an Ad hoc reviewer for the Cancer Genetics Study Section, the DOD Breast Cancer Research Program Programmatic Review, and the Clinical Integrative and Molecular Gastroenterology Study Sections. Kevin Pruitt received a B.S. in Chemical Engineering from UT-Austin and completed his Ph.D. training in Pharmacology as an N.S.F. Predoctoral Fellow under the direction of Channing Der, Ph.D., at UNC-Chapel Hill. He then continued postdoctoral studies as an American Cancer Society Postdoctoral Fellow at the Johns Hopkins School of Medicine under Stephen Baylin, M.D. Dr. Pruitt became an assistant professor at the LSU Health Sciences Center – Shreveport in 2006 and currently directs a very successful research program for which he has secured NIH/NCI funding (R01). The Pruitt laboratory has made major contributions in the study of sirtuin proteins and cancer epigenetics and has published papers in high impact science journals. Dr. Pruitt serves as an Ad hoc reviewer for the Cancer Genetics Study Section, the DOD Breast Cancer Research Program Programmatic Review, and the Clinical Integrative and Molecular Gastroenterology Study Sections.

Cancer,Molecular Gastroenterology